Sequencing Therapies in the Third-Line and Beyond Setting for MCL
A panel of experts discuss how to sequence BTK inhibitors and CAR T-cell therapies in patients with MCL.
Source: onclive.com
Stay updated with breaking news from Beyond Setting. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A panel of experts discuss how to sequence BTK inhibitors and CAR T-cell therapies in patients with MCL.
Peter Martin, MD, discusses how to sequence bispecific T-cell engagers and CAR T-cell therapies in the third-line and beyond setting for FL.